Comparison of Quality of Life of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
- Author:
Eun Ji KIM
1
Author Information
1. Samsung Medical Center, Seoul, Korea. silvermouse.kim@samsung.com
- Publication Type:Original Article
- Keywords:
Quality of life;
Autologous hematopoietic stem cell transplantation;
Allogeneic hematopoietic stem cell transplantation
- MeSH:
Hematopoietic Stem Cell Transplantation;
Hematopoietic Stem Cells;
Humans;
Long-Term Care;
Quality of Life
- From:Journal of Korean Oncology Nursing
2008;8(1):50-60
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The purpose of this study was to compare Quality of life (QOL) in type and time after Hematopoietic stem cell tansplantation (HSCT) for patients with hematologic cancer. METHOD: This study was cross-sectional. The autologous recipients was 120, the allogeneic recipients was 237. The obtained data were analyzed using T-test, One-way ANOVA, Scheffe's test. RESULTS: No significant differences were total QOL between the autologous and allogeneic recipients. But the autologous recipients reported better status than the allogeneic recipients in physical domain, especially 1-3 yr after HSCT. There was poorer QOL of 1-3 yr compared to 1 yr after HSCT in physical, psychological and social domain between the two groups. QOL in time after HSCT of the autologous recipients was significance differences in psychological, social domain. And QOL in time after HSCT of the allogeneic recipients was significant differences in physical, psychological and social domain. CONCLUSIONS: QOL of recipients undergoing HSCT is recovered beyond 3 yr point. Accordingly, long term care and service is essential to recipients undergoing HSCT. And further studies with a longitudinal design are necessary.
